NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to slow ALS progression
Disease control Not yet recruitingThis study tests a new oral drug called Kamlanoflast in 40 people with ALS. The goal is to see if it is safe, tolerable, and can reduce inflammation and slow decline in muscle function over 24 weeks. Participants must be 18-75 years old, diagnosed with ALS, and have had symptoms …
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New cycling method aims to ease MS symptoms
Symptom relief Not yet recruitingThis study tests a new exercise called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking ability, fatigue, and quality of life better than standard training. The study will include 60 adults with MS who can walk …
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Apr 29, 2026 15:14 UTC